Loading…

7517 POSTER Clinical tolerability of trabectedin administered by two different schedules (weekly for 3 of 4 weeks vs q3 weeks) in patients with advanced/metastatic liposarcoma or leiomyosarcoma (L-sarcomas) progressing despite prior treatment with at least anthracycline and ifosfamide

Saved in:
Bibliographic Details
Published in:European journal of cancer supplements 2007, Vol.5 (4), p.407-407
Main Authors: Chawla, S, Casali, P.G, von Mehren, M, Le Cesne, A, Blay, J.Y, Lebedinsky, C, Alfaro, V, Elsayed, Y, Michiels, B, Demetri, G.D
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(07)71494-5